Postdoctoral Scientist
Eli Lilly and Company
Dr. Shiyao Gao, PhD, MPH, is a postdoctoral scientist in the Global Patient Safety Pharmacoepidemiology team in Eli Lilly and Company. She received her PhD in Epidemiology from University of Pittsburgh. She has been actively involved in multiple pharmacoepidemiological and health outcomes studies. Her research interests include traumatic brain injury, epidemiology and pharmacoepidemiology methods.
